JPH06347733A - Treatment to give antimicrobial property to frame of spectacles and parts of spectacles - Google Patents
Treatment to give antimicrobial property to frame of spectacles and parts of spectaclesInfo
- Publication number
- JPH06347733A JPH06347733A JP16413793A JP16413793A JPH06347733A JP H06347733 A JPH06347733 A JP H06347733A JP 16413793 A JP16413793 A JP 16413793A JP 16413793 A JP16413793 A JP 16413793A JP H06347733 A JPH06347733 A JP H06347733A
- Authority
- JP
- Japan
- Prior art keywords
- chemical
- group
- spectacles
- compound
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000011282 treatment Methods 0.000 title claims description 7
- 230000000845 anti-microbial effect Effects 0.000 title abstract 5
- 229920000642 polymer Polymers 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 24
- 150000001875 compounds Chemical class 0.000 claims description 31
- 239000000126 substance Substances 0.000 claims description 31
- 230000000844 anti-bacterial effect Effects 0.000 claims description 24
- 239000000178 monomer Substances 0.000 claims description 18
- 150000001450 anions Chemical class 0.000 claims description 12
- -1 betaine compound Chemical class 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- 229920002554 vinyl polymer Polymers 0.000 claims description 11
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 8
- 125000002947 alkylene group Chemical group 0.000 claims description 6
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 5
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 claims description 4
- 229920006163 vinyl copolymer Polymers 0.000 claims description 3
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 2
- 229960003237 betaine Drugs 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 2
- 238000003672 processing method Methods 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 150000003864 primary ammonium salts Chemical class 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 235000019646 color tone Nutrition 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 42
- 238000012360 testing method Methods 0.000 description 24
- 238000006243 chemical reaction Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 15
- 229920001577 copolymer Polymers 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 11
- 239000003242 anti bacterial agent Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 9
- 206010015150 Erythema Diseases 0.000 description 8
- 229920005989 resin Polymers 0.000 description 8
- 239000011347 resin Substances 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 7
- 231100000321 erythema Toxicity 0.000 description 7
- 238000010438 heat treatment Methods 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 238000001226 reprecipitation Methods 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 125000001309 chloro group Chemical group Cl* 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- ZBESASFHIWDSCJ-WCWDXBQESA-N (e)-4-(4-octadecylphenyl)-4-oxobut-2-enoic acid Chemical compound CCCCCCCCCCCCCCCCCCC1=CC=C(C(=O)\C=C\C(O)=O)C=C1 ZBESASFHIWDSCJ-WCWDXBQESA-N 0.000 description 3
- ZRZHXNCATOYMJH-UHFFFAOYSA-N 1-(chloromethyl)-4-ethenylbenzene Chemical compound ClCC1=CC=C(C=C)C=C1 ZRZHXNCATOYMJH-UHFFFAOYSA-N 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000000160 carbon, hydrogen and nitrogen elemental analysis Methods 0.000 description 3
- 238000007334 copolymerization reaction Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000010908 decantation Methods 0.000 description 3
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 238000004898 kneading Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000009840 oxygen flask method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000005956 quaternization reaction Methods 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 150000003440 styrenes Chemical class 0.000 description 3
- VEKIYFGCEAJDDT-UHFFFAOYSA-N 2-pyridin-3-ylpyridine Chemical compound N1=CC=CC=C1C1=CC=CN=C1 VEKIYFGCEAJDDT-UHFFFAOYSA-N 0.000 description 2
- MWVTWFVJZLCBMC-UHFFFAOYSA-N 4,4'-bipyridine Chemical compound C1=NC=CC(C=2C=CN=CC=2)=C1 MWVTWFVJZLCBMC-UHFFFAOYSA-N 0.000 description 2
- 229920000178 Acrylic resin Polymers 0.000 description 2
- 239000004925 Acrylic resin Substances 0.000 description 2
- 208000019300 CLIPPERS Diseases 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical class C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 2
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 229920003180 amino resin Polymers 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 238000012662 bulk polymerization Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 125000004965 chloroalkyl group Chemical group 0.000 description 2
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- VEAZEPMQWHPHAG-UHFFFAOYSA-N n,n,n',n'-tetramethylbutane-1,4-diamine Chemical compound CN(C)CCCCN(C)C VEAZEPMQWHPHAG-UHFFFAOYSA-N 0.000 description 2
- TXXWBTOATXBWDR-UHFFFAOYSA-N n,n,n',n'-tetramethylhexane-1,6-diamine Chemical compound CN(C)CCCCCCN(C)C TXXWBTOATXBWDR-UHFFFAOYSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 238000010557 suspension polymerization reaction Methods 0.000 description 2
- 229950011008 tetrachloroethylene Drugs 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- JPZYXGPCHFZBHO-UHFFFAOYSA-N 1-aminopentadecane Chemical compound CCCCCCCCCCCCCCCN JPZYXGPCHFZBHO-UHFFFAOYSA-N 0.000 description 1
- PBLNBZIONSLZBU-UHFFFAOYSA-N 1-bromododecane Chemical compound CCCCCCCCCCCCBr PBLNBZIONSLZBU-UHFFFAOYSA-N 0.000 description 1
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- NCDBYAPSWOPDRN-UHFFFAOYSA-N 2-[dichloro(fluoro)methyl]sulfanylisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(SC(Cl)(Cl)F)C(=O)C2=C1 NCDBYAPSWOPDRN-UHFFFAOYSA-N 0.000 description 1
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
- RMHQDKYZXJVCME-UHFFFAOYSA-N 2-pyridin-4-ylpyridine Chemical compound N1=CC=CC=C1C1=CC=NC=C1 RMHQDKYZXJVCME-UHFFFAOYSA-N 0.000 description 1
- WKCYFSZDBICRKL-UHFFFAOYSA-N 3-(diethylamino)propan-1-ol Chemical compound CCN(CC)CCCO WKCYFSZDBICRKL-UHFFFAOYSA-N 0.000 description 1
- PYSGFFTXMUWEOT-UHFFFAOYSA-N 3-(dimethylamino)propan-1-ol Chemical compound CN(C)CCCO PYSGFFTXMUWEOT-UHFFFAOYSA-N 0.000 description 1
- IWTYTFSSTWXZFU-UHFFFAOYSA-N 3-chloroprop-1-enylbenzene Chemical class ClCC=CC1=CC=CC=C1 IWTYTFSSTWXZFU-UHFFFAOYSA-N 0.000 description 1
- OFDVABAUFQJWEZ-UHFFFAOYSA-N 3-pyridin-3-ylpyridine Chemical compound C1=CN=CC(C=2C=NC=CC=2)=C1 OFDVABAUFQJWEZ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
- BLFRQYKZFKYQLO-UHFFFAOYSA-N 4-aminobutan-1-ol Chemical compound NCCCCO BLFRQYKZFKYQLO-UHFFFAOYSA-N 0.000 description 1
- LQGKDMHENBFVRC-UHFFFAOYSA-N 5-aminopentan-1-ol Chemical compound NCCCCCO LQGKDMHENBFVRC-UHFFFAOYSA-N 0.000 description 1
- SUTWPJHCRAITLU-UHFFFAOYSA-N 6-aminohexan-1-ol Chemical compound NCCCCCCO SUTWPJHCRAITLU-UHFFFAOYSA-N 0.000 description 1
- KYJSXYQQYWMITG-UHFFFAOYSA-N 7-aminoheptan-1-ol Chemical compound NCCCCCCCO KYJSXYQQYWMITG-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WDCOJSGXSPGNFK-UHFFFAOYSA-N 8-aminooctan-1-ol Chemical compound NCCCCCCCCO WDCOJSGXSPGNFK-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 235000016068 Berberis vulgaris Nutrition 0.000 description 1
- 241000335053 Beta vulgaris Species 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- NAVYKAIILILPRK-UHFFFAOYSA-N [Cl-].[Br-].[NH3+]CCCCCC[NH3+] Chemical compound [Cl-].[Br-].[NH3+]CCCCCC[NH3+] NAVYKAIILILPRK-UHFFFAOYSA-N 0.000 description 1
- 238000003677 abuse test Methods 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 231100000460 acute oral toxicity Toxicity 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- TWFZGCMQGLPBSX-UHFFFAOYSA-N carbendazim Chemical compound C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- WSFMFXQNYPNYGG-UHFFFAOYSA-M dimethyl-octadecyl-(3-trimethoxysilylpropyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCC[Si](OC)(OC)OC WSFMFXQNYPNYGG-UHFFFAOYSA-M 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- MEGHWIAOTJPCHQ-UHFFFAOYSA-N ethenyl butanoate Chemical compound CCCC(=O)OC=C MEGHWIAOTJPCHQ-UHFFFAOYSA-N 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QABLOFMHHSOFRJ-UHFFFAOYSA-N methyl 2-chloroacetate Chemical compound COC(=O)CCl QABLOFMHHSOFRJ-UHFFFAOYSA-N 0.000 description 1
- CAAULPUQFIIOTL-UHFFFAOYSA-N methyl dihydrogen phosphate Chemical compound COP(O)(O)=O CAAULPUQFIIOTL-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- WFKDPJRCBCBQNT-UHFFFAOYSA-N n,2-dimethylprop-2-enamide Chemical compound CNC(=O)C(C)=C WFKDPJRCBCBQNT-UHFFFAOYSA-N 0.000 description 1
- YXVIGUHBJDFXKZ-UHFFFAOYSA-N n,n,n',n'-tetraethylbutane-1,4-diamine Chemical compound CCN(CC)CCCCN(CC)CC YXVIGUHBJDFXKZ-UHFFFAOYSA-N 0.000 description 1
- DIHKMUNUGQVFES-UHFFFAOYSA-N n,n,n',n'-tetraethylethane-1,2-diamine Chemical compound CCN(CC)CCN(CC)CC DIHKMUNUGQVFES-UHFFFAOYSA-N 0.000 description 1
- SRTOAFZPEOCBGW-UHFFFAOYSA-N n,n,n',n'-tetraethylhexane-1,6-diamine Chemical compound CCN(CC)CCCCCCN(CC)CC SRTOAFZPEOCBGW-UHFFFAOYSA-N 0.000 description 1
- OQIRZNNBUNOXTQ-UHFFFAOYSA-N n,n,n',n'-tetraethylpentane-1,5-diamine Chemical compound CCN(CC)CCCCCN(CC)CC OQIRZNNBUNOXTQ-UHFFFAOYSA-N 0.000 description 1
- RCZLVPFECJNLMZ-UHFFFAOYSA-N n,n,n',n'-tetraethylpropane-1,3-diamine Chemical compound CCN(CC)CCCN(CC)CC RCZLVPFECJNLMZ-UHFFFAOYSA-N 0.000 description 1
- RISIMDUICYECMH-UHFFFAOYSA-N n,n,n',n'-tetramethylhex-1-ene-1,6-diamine Chemical compound CN(C)CCCCC=CN(C)C RISIMDUICYECMH-UHFFFAOYSA-N 0.000 description 1
- DNOJGXHXKATOKI-UHFFFAOYSA-N n,n,n',n'-tetramethylpentane-1,5-diamine Chemical compound CN(C)CCCCCN(C)C DNOJGXHXKATOKI-UHFFFAOYSA-N 0.000 description 1
- DMQSHEKGGUOYJS-UHFFFAOYSA-N n,n,n',n'-tetramethylpropane-1,3-diamine Chemical compound CN(C)CCCN(C)C DMQSHEKGGUOYJS-UHFFFAOYSA-N 0.000 description 1
- ZIWDVJPPVMGJGR-UHFFFAOYSA-N n-ethyl-2-methylprop-2-enamide Chemical compound CCNC(=O)C(C)=C ZIWDVJPPVMGJGR-UHFFFAOYSA-N 0.000 description 1
- RDXBZXWKSIEKKS-UHFFFAOYSA-N n-ethyldecan-1-amine Chemical compound CCCCCCCCCCNCC RDXBZXWKSIEKKS-UHFFFAOYSA-N 0.000 description 1
- LWIPGCTWFZCIKX-UHFFFAOYSA-N n-ethyldodecan-1-amine Chemical compound CCCCCCCCCCCCNCC LWIPGCTWFZCIKX-UHFFFAOYSA-N 0.000 description 1
- IKVDMBQGHZVMRN-UHFFFAOYSA-N n-methyldecan-1-amine Chemical compound CCCCCCCCCCNC IKVDMBQGHZVMRN-UHFFFAOYSA-N 0.000 description 1
- OMEMQVZNTDHENJ-UHFFFAOYSA-N n-methyldodecan-1-amine Chemical compound CCCCCCCCCCCCNC OMEMQVZNTDHENJ-UHFFFAOYSA-N 0.000 description 1
- IHFXMTOFDQKABX-UHFFFAOYSA-N n-methylhexadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCNC IHFXMTOFDQKABX-UHFFFAOYSA-N 0.000 description 1
- SZEGKVHRCLBFKJ-UHFFFAOYSA-N n-methyloctadecan-1-amine Chemical compound CCCCCCCCCCCCCCCCCCNC SZEGKVHRCLBFKJ-UHFFFAOYSA-N 0.000 description 1
- SEGJNMCIMOLEDM-UHFFFAOYSA-N n-methyloctan-1-amine Chemical compound CCCCCCCCNC SEGJNMCIMOLEDM-UHFFFAOYSA-N 0.000 description 1
- YPHQUSNPXDGUHL-UHFFFAOYSA-N n-methylprop-2-enamide Chemical compound CNC(=O)C=C YPHQUSNPXDGUHL-UHFFFAOYSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Chemical compound [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229940085991 phosphate ion Drugs 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000005336 safety glass Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- APMORJJNVZMVQK-KXUCPTDWSA-N tert-butyl (1R,2R,4S)-4-chloro-2-methylcyclohexane-1-carboxylate Chemical compound C[C@@H]1C[C@@H](Cl)CC[C@H]1C(=O)OC(C)(C)C APMORJJNVZMVQK-KXUCPTDWSA-N 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 229940045860 white wax Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Landscapes
- Eyeglasses (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は眼鏡フレーム及び眼鏡部
品に抗菌性を付与するための処理方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a processing method for imparting antibacterial properties to eyeglass frames and eyeglass parts.
【0002】[0002]
【従来の技術】眼鏡フレーム等に付着する汗や分泌物等
からの汚れは不快感及び悪臭をもたらすのみならず、皮
膚常在細菌である黄色ブドウ球菌等の雑菌の繁殖源とな
り人体に悪影響を及ぼす恐れがある。2. Description of the Related Art Dirt from sweat or secretions attached to eyeglass frames, etc. not only cause discomfort and malodor, but also become a breeding source of various bacteria such as Staphylococcus aureus which is a skin-resident bacterium and adversely affects the human body. May affect
【0003】そこで、これらの防止策として、種々の研
究がなされている。例えば、低分子化合物の抗菌剤等を
樹脂に混練し、眼鏡フレームに塗布する方法(特開平4
−194815号、実開平3−71319号、実開平4
−120922号)、低分子化合物の抗菌剤等を樹脂ペ
レツトにして眼鏡フレームを製造する方法(特開平3−
249725号)、抗菌性金属を無機系担体に担持させ
た後、樹脂に混練し、眼鏡フレームを製造する方法(実
開平3−47513号)、あるいは抗菌性金属を無機系
担体に担持させた後、樹脂に混練し、眼鏡フレームを被
覆する方法(実開平3−69122号)などがある。Therefore, various studies have been made as measures to prevent these problems. For example, a method of kneading a low-molecular compound antibacterial agent or the like with a resin and applying the kneaded resin to a spectacle frame (Japanese Patent Laid-Open No. 4-312058)
-194815, Actual Kaihei 3-71319, Actual Kaihei 4
No. 120922), a method for producing a spectacle frame by using a resin pellet with an antibacterial agent of a low molecular weight compound (Japanese Patent Laid-Open No. 3-2021).
249725), a method of supporting an antibacterial metal on an inorganic carrier and then kneading with a resin to produce an eyeglass frame (Actual No. 3-47513), or after supporting an antibacterial metal on an inorganic carrier. , A method of kneading with a resin and covering the spectacle frame (Jitsukaihei 3-69122).
【0004】しかしながら、低分子化合物の抗菌剤等を
使用する方法では、該眼鏡フレームの使用中に、抗菌剤
が徐々に溶出し、人体に対して悪影響を及ぼす恐れがあ
り、且つ該眼鏡フレームの抗菌力を持続できない等の欠
点がある。又、抗菌性金属を無機系担体に担持させたも
のを使用する方法では、透明な色調が出し難く、且つ、
眼鏡フレームの物性及び強度を低下させる懸念がある。However, in the method of using an antibacterial agent or the like of a low molecular weight compound, the antibacterial agent is gradually eluted during use of the spectacle frame, which may adversely affect the human body, and There are drawbacks such as the inability to maintain antibacterial activity. Further, in the method of using an antibacterial metal supported on an inorganic carrier, it is difficult to obtain a transparent color tone, and
There is a concern that the physical properties and strength of the spectacle frame may deteriorate.
【0005】[0005]
【発明が解決しようとする課題】本発明の目的は抗菌剤
が溶出することがなく長期間にわたつて優れた抗菌力を
持続することができ、且つ眼鏡フレーム及び眼鏡部品本
来の色調を損なうことも無く、安全性にも優れた、眼鏡
フレーム及び眼鏡部品に抗菌性を付与するための処理方
法を提供することにある。The object of the present invention is to prevent the antibacterial agent from eluting and to maintain the excellent antibacterial activity over a long period of time, and to impair the original color tone of the spectacle frame and spectacle parts. Another object of the present invention is to provide a treatment method for imparting antibacterial properties to eyeglass frames and eyeglass parts, which is excellent in safety.
【0006】[0006]
【課題を解決するための手段】本発明は抗菌性を有する
ポリマーで、眼鏡フレーム及び眼鏡部品の表面をコーテ
イングすることを特徴とする眼鏡フレーム及び眼鏡部品
に抗菌性を付与するための処理方法に係る。The present invention relates to a treatment method for imparting antibacterial properties to eyeglass frames and eyeglass parts, which is characterized in that the surface of the eyeglass frames and eyeglass parts is coated with a polymer having antibacterial properties. Pertain.
【0007】本発明において抗菌性を有するポリマーと
して好ましくは非架橋性ビニルモノマーから誘導される
構成単位と化6で表わされる構成単位を含むビニル系共
重合体を使用できる。In the present invention, as the polymer having antibacterial properties, a vinyl-based copolymer containing a structural unit derived from a non-crosslinkable vinyl monomer and a structural unit represented by Chemical formula 6 can be preferably used.
【0008】[0008]
【化6】 [Chemical 6]
【0009】〔式中R1は水素原子又はメチル基を、A
はフエニレン基を、R2は炭素数1〜2のアルキレン基
を、Bは第4級アンモニウム塩またはベタイン型化合物
を含有する基を示し、Aは置換基を含んでいてもよ
い。〕[Wherein R 1 represents a hydrogen atom or a methyl group,
Represents a phenylene group, R 2 represents an alkylene group having 1 to 2 carbon atoms, B represents a group containing a quaternary ammonium salt or a betaine compound, and A may contain a substituent. ]
【0010】本発明の該ビニル系共重合体において一般
式(1)のBとしては例えば下記構造式(2)〜(5)
で表される基を挙げることができる。In the vinyl copolymer of the present invention, B in the general formula (1) is, for example, the following structural formulas (2) to (5).
The group represented by can be mentioned.
【0011】[0011]
【化7】 [Chemical 7]
【0012】[0012]
【化8】 [Chemical 8]
【0013】[0013]
【化9】 [Chemical 9]
【0014】[0014]
【化10】 [Chemical 10]
【0015】〔式中、ビピリジンは、4,4'−,2,2'−,
2,3'−,2,4'−,3,3'−,3,4'−の異性体を示し、X,
Yはアニオンで同一又は異なつていてもよく、X, Yが
それぞれ1価のアニオン或いは(X, Y)が2価のアニ
オン1個であつてもよい。R3は炭素数6〜18のアルキ
ル基、R4は炭素数2〜10のアルキレン基、R5〜R8は
同一又は異なつていてもよく、炭素数1〜3のアルキル
基、R9は炭素数1〜3のアルキレン基を示し、いずれ
も置換基を含んでいてもよい。〕[In the formula, bipyridine is 4,4'-, 2,2'-,
2,3'-, 2,4'-, 3,3'-, 3,4'-isomers are shown, and X,
Y is an anion which may be the same or different, and each of X and Y may be a monovalent anion or (X, Y) may be one divalent anion. R 3 is an alkyl group having 6 to 18 carbon atoms, R 4 is an alkylene group having 2 to 10 carbon atoms, R 5 to R 8 may be the same or different, and are an alkyl group having 1 to 3 carbon atoms, R 9 Represents an alkylene group having 1 to 3 carbon atoms, and each may contain a substituent. ]
【0016】該化合物(1)は、広範囲にわたつて強力
な抗菌スペクトルを有し、溶媒可溶で、接着力が大き
く、且つ、抗菌性のある被膜を形成しやすい。該化合物
(1)で眼鏡フレーム及び眼鏡部品の表面をコーテイン
グすれば抗菌剤が溶出することがなく長期間にわたつて
優れた抗菌力を持続することができる。しかも、該化合
物(1)は透明であるから眼鏡フレーム及び眼鏡部品本
来の色調を損なうことも無い。The compound (1) has a strong antibacterial spectrum over a wide range, is soluble in a solvent, has a large adhesive force, and easily forms an antibacterial film. When the surface of the spectacle frame and the spectacle part is coated with the compound (1), the antibacterial agent is not eluted and the excellent antibacterial activity can be maintained for a long period of time. Moreover, since the compound (1) is transparent, it does not impair the original color tone of the spectacle frame and spectacle parts.
【0017】又、該化合物(1)はマウス急性経口毒性
5,000mg/kg以上で、兎皮膚一次刺激性試験においても
刺激性が無く、人体に対して、安心して使用することが
できる。Further, the compound (1) is acute oral toxicity in mice.
It is 5,000 mg / kg or more, has no irritation in the rabbit skin primary irritation test, and can be safely used for the human body.
【0018】本発明の眼鏡フレーム及び眼鏡部品の表面
コーテイング方法としては、ガン吹き塗布又は刷毛によ
るコーテイングなどの公知の方法が用いられる。その
際、該化合物(1)の単独溶液で、あるいは既存の塗膜
形成組成物と混合して使用することもできる。又、該化
合物(1)と市販の抗菌剤等を混合して使用することも
可能である。As a method for coating the surface of the spectacle frame and the spectacle component of the present invention, known methods such as gun spray coating or coating with a brush are used. At that time, the compound (1) may be used as a single solution or as a mixture with an existing film-forming composition. It is also possible to use a mixture of the compound (1) and a commercially available antibacterial agent or the like.
【0019】本発明において抗菌性を付与することがで
きる眼鏡フレーム及び眼鏡部品としては、特に限定され
ないが、例えば眼鏡フレームとしては所謂、通常の眼鏡
の他、スポーツグラス、安全眼鏡及びフアツシヨングラ
ス等を含み、眼鏡部品としては、鼻当てパツド、耳かけ
モダン等を含む。In the present invention, the spectacle frame and spectacle parts capable of imparting antibacterial property are not particularly limited, but for example, so-called normal spectacles for spectacle frames, sports glasses, safety glasses and fashion glasses are also used. And the like, and the spectacle parts include a nose pad and a modern earpiece.
【0020】次に化合物(1)を溶解するための溶媒と
しては、該化合物(1)を溶解するものであれば特に限
定されず、例えば、メタノール、エタノール、テトラヒ
ドロフラン、ジメチルホルムアミド、クロロホルム、塩
化メチレンなど、あるいは、それらの混合溶媒を挙げる
ことができる。Next, the solvent for dissolving the compound (1) is not particularly limited as long as it can dissolve the compound (1), and examples thereof include methanol, ethanol, tetrahydrofuran, dimethylformamide, chloroform and methylene chloride. Or the like, or a mixed solvent thereof.
【0021】又、該化合物(1)と混合使用できる塗膜
形成組成物としては、眼鏡フレーム等のコーテイングに
適するものであれば特に限定されず、例えば、アクリル
樹脂、アミノ樹脂、ポリウレタン樹脂、シリコン樹脂な
ど、あるいはそれらの混合物を挙げることができる。The coating film-forming composition which can be mixed with the compound (1) is not particularly limited as long as it is suitable for coating eyeglass frames and the like, and examples thereof include acrylic resin, amino resin, polyurethane resin and silicone. Resin, etc., or a mixture thereof can be mentioned.
【0022】更に、化合物(1)と混合して使用するこ
とができる市販の抗菌剤としては特に限定されないが、
例えば、塩化ベンザルコニウム、塩酸アルキルジアミノ
エチルグリシン、3−(トリメトキシシリル)−プロピ
ルオクタデシルジメチルアンモニウムクロライド、2−
(4'−チアゾリル)ベンゾイミダゾール、2−(カー
ボメトキシアミノ)ベンゾイミダゾール及びN−(フル
オロジクロロメチルチオ)フタルイミドなどを挙げるこ
とができる。Further, the commercially available antibacterial agent which can be used by mixing with the compound (1) is not particularly limited,
For example, benzalkonium chloride, alkyldiaminoethylglycine hydrochloride, 3- (trimethoxysilyl) -propyloctadecyldimethylammonium chloride, 2-
Examples thereof include (4′-thiazolyl) benzimidazole, 2- (carbomethoxyamino) benzimidazole and N- (fluorodichloromethylthio) phthalimide.
【0023】一般式(1)において、R3のアルキル基
は炭素数が6〜18の範囲のものが用いられるが、抗菌力
の観点から、8〜14がより好ましい。尚、アニオンにつ
いては特に限定されず、例えば、塩素イオン、臭素イオ
ン、ヨウ素イオン、過塩素酸イオン、酢酸イオン、メチ
ル硫酸イオン、ベンゼルスルホン酸イオン、クロルベン
ゼンスルホン酸イオン、トルエンスルホン酸イオンなど
の1価の陰イオン、硫酸イオン、メチルリン酸イオンな
どの2価の陰イオンを挙げることができる。共重合体の
数平均分子量Mnは5,000〜5,000,000、好ましくは10,00
0〜2,000,000、Mw/Mn=1.1〜7.0(Mwは重量平均分
子量)が望ましい。In the general formula (1), the alkyl group of R 3 has a carbon number in the range of 6 to 18, but is preferably 8 to 14 from the viewpoint of antibacterial activity. The anion is not particularly limited, and examples thereof include chlorine ion, bromine ion, iodine ion, perchlorate ion, acetate ion, methylsulfate ion, benzenesulfonate ion, chlorobenzenesulfonate ion, toluenesulfonate ion and the like. The monovalent anion, the sulfate ion, and the divalent anion such as methyl phosphate ion can be mentioned. The number average molecular weight Mn of the copolymer is 5,000 to 5,000,000, preferably 10,000.
0-2,000,000, Mw / Mn = 1.1-7.0 (Mw is a weight average molecular weight) is desirable.
【0024】該共重合体に於いて構成単位(1)の比率
は、0.1〜90モル%、好ましくは5〜60モル%である。The proportion of the structural unit (1) in the copolymer is 0.1 to 90 mol%, preferably 5 to 60 mol%.
【0025】該共重合体はクロロ(C1〜2アルキル)ス
チレン類と共重合可能な非架橋性ビニルモノマーとを共
重合させて、共重合体となし、次いでこのクロロアルキ
ル基のクロル(塩素)原子を前記の第4級アンモニウム
塩またはベタイン型化合物で置換することにより製造さ
れる。また予め、クロロアルキルスチレン類の塩素原子
を第4級アンモニウム塩またはベタイン型化合物で置換
した後、共重合可能な非架橋性ビニルモノマーと共重合
させて製造することもできる。The copolymer is obtained by copolymerizing chloro (C 1-2 alkyl) styrenes with a non-crosslinkable vinyl monomer which can be copolymerized to form a copolymer, and then chloro (chlorine) of the chloroalkyl group. ) Atoms are replaced with the quaternary ammonium salt or betaine type compound described above. Alternatively, it can be produced by previously substituting the chlorine atom of chloroalkylstyrenes with a quaternary ammonium salt or a betaine-type compound and then copolymerizing with a copolymerizable non-crosslinkable vinyl monomer.
【0026】本発明で使用されるクロロ(C1〜2アルキ
ル)スチレン類としては、p−クロロメチルスチレンが
好適であるが、他の置換基を有するクロロ(C1〜2アル
キル)スチレン誘導体であつてもよい。As the chloro (C 1-2 alkyl) styrenes used in the present invention, p-chloromethylstyrene is preferable, but it is a chloro (C 1-2 alkyl) styrene derivative having another substituent. You can buy it.
【0027】非架橋性ビニルモノマーとしては例えば、
スチレン、p−メチルスチレン等のスチレン系モノマ
ー;アクリル酸エチル、アクリル酸ラウリル等のアクリ
ル酸エステル系モノマー;メタクリル酸メチル、メタク
リル酸エチル、メタクリル酸ラウリル等のメタクリル酸
エステル系モノマー;酢酸ビニル、酪酸ビニル等のビニ
ルエステル系モノマー;N−メチルアクリルアミド、N
−エチルアクリルアミド、N−メチルメタクリルアミ
ド、N−エチルメタクリルアミド等のN−アルキル置換
(メタ)アクリルアミド;アクリロニトリル、メタクリ
ロニトリル等のニトリル系モノマー等が挙げられるが、
クロロメチルスチレン類と共重合可能なモノマーであれ
ば、前記モノマーに限定されない。これらの単量体は、
単独でまたは2種以上混合して用いることが可能であ
る。As the non-crosslinkable vinyl monomer, for example,
Styrene-based monomers such as styrene and p-methylstyrene; acrylic ester-based monomers such as ethyl acrylate and lauryl acrylate; methacrylate-based monomers such as methyl methacrylate, ethyl methacrylate, lauryl methacrylate; vinyl acetate, butyric acid Vinyl ester monomers such as vinyl; N-methyl acrylamide, N
-N-alkyl-substituted (meth) acrylamides such as -ethylacrylamide, N-methylmethacrylamide, and N-ethylmethacrylamide; and nitrile-based monomers such as acrylonitrile and methacrylonitrile.
The monomer is not limited to the above monomers as long as it is a monomer copolymerizable with chloromethylstyrenes. These monomers are
It is possible to use alone or in combination of two or more.
【0028】クロロアルキルスチレン、非架橋性共重合
ビニルモノマーの共重合に当たつての仕込みモル比は、
1〜60:40〜99程度が好ましい。The molar ratio of the chloroalkyl styrene and the non-crosslinkable copolymerized vinyl monomer to be copolymerized is as follows:
1-60: 40-99 is preferable.
【0029】共重合の方法としては、従来公知の塊状重
合、溶液重合、懸濁重合等を用いることができる。As the copolymerization method, conventionally known bulk polymerization, solution polymerization, suspension polymerization and the like can be used.
【0030】次に該共重合体の製造方法の一例を反応式
で示す。Next, an example of a method for producing the copolymer is shown by a reaction formula.
【0031】[0031]
【化11】 [Chemical 11]
【0032】[0032]
【化12】 [Chemical 12]
【0033】[0033]
【化13】 [Chemical 13]
【0034】[0034]
【化14】 [Chemical 14]
【0035】[0035]
【化15】 [Chemical 15]
【0036】[0036]
【化16】 [Chemical 16]
【0037】[0037]
【化17】 [Chemical 17]
【0038】[0038]
【化18】 [Chemical 18]
【0039】[0039]
【化19】 [Chemical 19]
【0040】[0040]
【化20】 [Chemical 20]
【0041】上記(1)において化合物(DP)は化合
物RXに対して通常約1.0〜10.0倍モル、好ましくは約
1.1〜2.1倍モル反応させるのが良い。反応は有機溶媒中
で行うのが好ましく、一般に約60〜110℃の反応温度が
好適である。生成物(Q)は抽出、再結晶などの方法に
より精製することができる。(2)の重合は通常の懸濁
重合、溶液重合、塊状重合などの方法で行なうことがで
き、得られたポリマー(PCS)は再沈殿、洗浄等の方
法で精製することができる。(3)の反応においては、
ポリマー(PCS)のクロロメチル基1当量に対して化
合物(Q)を通常約0.1〜2.0当量、好ましくは約0.8〜
1.2当量反応させる。反応は有機溶媒中で行うのが好ま
しく、一般に約60〜100℃の反応温度が好適である。生
成物(BPCQ)は再沈殿、洗浄などの方法により精製
することができる。(4)〜(7)についても、ほぼ同
様の方法により製造することができる。In the above (1), the compound (DP) is usually about 1.0 to 10.0 times mol, preferably about about 10 times the compound RX.
It is better to carry out 1.1- to 2.1-fold molar reaction. The reaction is preferably carried out in an organic solvent, generally a reaction temperature of about 60 to 110 ° C. being suitable. The product (Q) can be purified by a method such as extraction and recrystallization. The polymerization of (2) can be carried out by a usual method such as suspension polymerization, solution polymerization or bulk polymerization, and the obtained polymer (PCS) can be purified by a method such as reprecipitation or washing. In the reaction of (3),
The compound (Q) is usually used in an amount of about 0.1 to 2.0 equivalents, preferably about 0.8 to 1 equivalent of the chloromethyl group of the polymer (PCS).
React 1.2 equivalents. The reaction is preferably carried out in an organic solvent, generally a reaction temperature of about 60-100 ° C being suitable. The product (BPCQ) can be purified by a method such as reprecipitation and washing. Also (4) to (7) can be manufactured by substantially the same method.
【0042】(8)の反応においては、化合物(PC
S)に対して長鎖アルキルアミン約0.8〜2.0倍モル反応
させるのが好ましい。In the reaction of (8), the compound (PC
It is preferred that the long-chain alkylamine is reacted in a molar amount of about 0.8 to 2.0 times that of S).
【0043】(9)において、NaOH溶液の濃度は一
般に約0.5〜2.0規定溶液を用いるのが好適である。In (9), it is generally preferred that the concentration of the NaOH solution is about 0.5 to 2.0N.
【0044】(10)で、化合物(PCS−AA)に対
し、モノクロロ酢酸は約1〜2倍モル反応させるのが良
い。反応は有機溶媒中で行うのが好ましく、約2〜10時
間、還流するのが好適である。生成物(PCS−BT)
は再沈殿、あるいは洗浄などの方法により精製すること
ができる。In (10), it is preferable to react monochloroacetic acid with the compound (PCS-AA) in a molar amount of about 1 to 2 times. The reaction is preferably carried out in an organic solvent, preferably at reflux for about 2-10 hours. Product (PCS-BT)
Can be purified by a method such as reprecipitation or washing.
【0045】該共重合体を製造するために用いられるビ
ピリジンとしては、2,2'−ビピリジン、2,3'−ビピリジ
ン、2,4'−ビピリジン、3,3'−ビピリジン、3,4'−ビピ
リジン、4,4'−ビピリジンおよびそれらの混合物等が使
用される。The bipyridine used for producing the copolymer includes 2,2'-bipyridine, 2,3'-bipyridine, 2,4'-bipyridine, 3,3'-bipyridine and 3,4 '. -Bipyridine, 4,4'-bipyridine and mixtures thereof are used.
【0046】ハロゲン化アルキルとしては炭素数6〜18
のクロル、ブロムまたはヨウ素等のハロゲン化アルキル
が使用される。The alkyl halide has 6 to 18 carbon atoms.
Alkyl halides such as chlorine, bromine or iodine are used.
【0047】アルキルジアミンとしては、例えばN,N,
N',N'−テトラメチルエチレンジアミン、N,N,N',
N'−テトラメチル−1,3−プロパンジアミン、N,N,
N',N'−テトラメチル−1,4−ブタンジアミン、N,N,
N',N'−テトラメチル−1,5−ペンタンジアミン、N,
N,N',N'−テトラメチル−1,6−ヘキサンジアミン、
N,N,N',N'−テトラエチルエチレンジアミン、N,
N,N',N'−テトラエチル−1,3−プロパンジアミン、
N,N,N',N'−テトラエチル−1,4−ブタンジアミン、
N,N,N',N'−テトラエチル−1,5−ペンタンジアミ
ン、N,N,N',N'−テトラエチル−1,6−ヘキサンジア
ミンなどが使用される。As the alkyldiamine, for example, N, N,
N ', N'-tetramethylethylenediamine, N, N, N',
N'-tetramethyl-1,3-propanediamine, N, N,
N ', N'-tetramethyl-1,4-butanediamine, N, N,
N ', N'-tetramethyl-1,5-pentanediamine, N,
N, N ', N'-tetramethyl-1,6-hexanediamine,
N, N, N ', N'-tetraethylethylenediamine, N,
N, N ', N'-tetraethyl-1,3-propanediamine,
N, N, N ', N'-tetraethyl-1,4-butanediamine,
N, N, N ', N'-tetraethyl-1,5-pentanediamine, N, N, N', N'-tetraethyl-1,6-hexanediamine and the like are used.
【0048】アミノアルコールとしては、例えば2−ア
ミノエタノール、3−アミノ−プロパノール、4−アミ
ノブタノール、5−アミノペンタノール、6−アミノヘ
キサノール、7−アミノヘプタノール、8−アミノオク
タノール、2−(ジメチルアミノ)エタノール、2−
(ジエチルアミノ)エタノール、3−(ジメチルアミ
ノ)プロパノール、3−(ジエチルアミノ)プロパノー
ル等が用いられる。Examples of amino alcohols include 2-aminoethanol, 3-amino-propanol, 4-aminobutanol, 5-aminopentanol, 6-aminohexanol, 7-aminoheptanol, 8-aminooctanol and 2- ( Dimethylamino) ethanol, 2-
(Diethylamino) ethanol, 3- (dimethylamino) propanol, 3- (diethylamino) propanol and the like are used.
【0049】第2級アミンとしては、N−メチルオクチ
ルアミン、N−メチルデシルアミン、N−メチルドデシ
ルアミン、N−メチルミリスチルアミン、N−メチルセ
チルアミン、N−メチルステアリルアミン、N−エチル
オクチルアミン、N−エチルデシルアミン、N−エチル
ドデシルアミンなどが用いられる。Examples of the secondary amine include N-methyloctylamine, N-methyldecylamine, N-methyldodecylamine, N-methylmyristylamine, N-methylcetylamine, N-methylstearylamine and N-ethyloctyl. Amine, N-ethyldecylamine, N-ethyldodecylamine and the like are used.
【0050】尚、化合物(1)のアニオンについては、
公知の手法に従つて、望ましいタイプのものを得ること
ができる。例えば、あらかじめクロロアルキルスチレン
類と第四級アンモニウム塩またはベタイン型化合物とを
反応させた段階で、あるいは、最終化合物とした該共重
合体の段階で、それぞれの化合物を可溶性溶媒に溶解し
たのち、希望アニオンを含有する塩を加え、反応後、濃
縮、乾燥、精製する方法等によつて、アニオンを交換す
ることができる。Regarding the anion of the compound (1),
The desired type can be obtained according to known techniques. For example, at the stage of previously reacting chloroalkylstyrenes with a quaternary ammonium salt or a betaine-type compound, or at the stage of the copolymer as the final compound, after dissolving each compound in a soluble solvent, The anion can be exchanged by adding a salt containing a desired anion, concentrating, drying and purifying after the reaction.
【0051】該共重合体はクロロアルキルスチレン類と
非架橋性ビニルモノマーとのコポリマーを原料としてい
るため、クロロアルキルスチレン類のホモポリマーを原
料としたものに比べ、以下の点で優れている。Since the copolymer uses a copolymer of chloroalkylstyrenes and a non-crosslinkable vinyl monomer as a raw material, it is excellent in the following points as compared with a homopolymer of chloroalkylstyrenes as a raw material.
【0052】即ち、前記コポリマーを用いて第4級アン
モニウム塩またはベタイン型化合物を導入した場合は、
前記ホモポリマーを用いた場合に比べ、未反応クロロア
ルキル残基が少ないため、物性の安定性と、人体に対す
る安全性に優れている。その上、クロロアルキルスチレ
ン類よりも安価な非架橋性ビニルモノマーを用いて共重
合することにより、製造コストの低下を図ることができ
る。本発明において上記ビニル系共重合体は被膜を形成
しやすく、かつ、接着力が大きい。That is, when a quaternary ammonium salt or a betaine type compound is introduced using the above copolymer,
Since the amount of unreacted chloroalkyl residues is smaller than that in the case of using the homopolymer, the stability of physical properties and the safety for human body are excellent. In addition, copolymerization using a non-crosslinkable vinyl monomer that is cheaper than chloroalkylstyrenes can reduce the production cost. In the present invention, the vinyl copolymer is easy to form a film and has a large adhesive force.
【0053】[0053]
【実施例】次に本発明を実施例により説明する。EXAMPLES The present invention will now be described with reference to examples.
【0054】実施例1 攪拌機、還流コンデンサー、窒素導入管及び滴下ロート
をつけた1l 四ツ口フラスコにメチルアルコール 300m
l及び4,4'−ビピリジル 149.8g(0.96モル)を仕込んだ
後、乾燥窒素を導入しつつ、70℃の油浴上で加熱しなが
ら滴下ロートより、ラウリルブロマイド(LBと略す)
29.9g(0.12モル)を2時間かけて滴下した。18時間加
熱攪拌した後、溶媒を除去し、メタノール:アセトン系
より再結晶した。該結晶を室温で真空ポンプにより、減
圧乾燥したところ、褐色粉末状の臭化N−ラウリル−4,
4'−ピリジルピリジニウム(以下Qと略す)42.5g(0.1
1モル)が得られた。LBに対するQの収率は87.5%で
あつた。Qは1H−NMR、IR、CHN分析、コロイ
ド滴定、及び酸素フラスコ燃焼法による全ハロゲンの定
量で化学構造を確認をした。Example 1 300 ml of methyl alcohol was placed in a 1-liter four-necked flask equipped with a stirrer, a reflux condenser, a nitrogen introducing tube and a dropping funnel.
After charging l and 4,4'-bipyridyl 149.8g (0.96mol), lauryl bromide (abbreviated as LB) was added from a dropping funnel while introducing dry nitrogen and heating on an oil bath at 70 ° C.
29.9 g (0.12 mol) was added dropwise over 2 hours. After heating and stirring for 18 hours, the solvent was removed, and recrystallization from a methanol: acetone system was performed. The crystals were dried under reduced pressure by a vacuum pump at room temperature to obtain brown powder of N-lauryl bromide-4,
4'-pyridylpyridinium (hereinafter abbreviated as Q) 42.5 g (0.1
1 mol) was obtained. The yield of Q based on LB was 87.5%. The chemical structure of Q was confirmed by 1 H-NMR, IR, CHN analysis, colloid titration, and quantification of total halogen by oxygen flask combustion method.
【0055】次いで常法の溶液重合により、p−クロロ
メチルスチレン(CMSと略す)15.3g(0.10モル)と
スチレン(STと略す)93.6g(0.90モル)との共重合
反応を行うことにより、白色ポリマーが生成した。反応
混合溶液を冷却後、デカンテーシヨンにより、該白色ポ
リマーを取り出し、次に、テトラヒドロフラン/メタノ
ール系で再沈殿を3回くりかえし、未反応モノマーを除
去、精製した。該精製ポリマーを一昼夜、加熱減圧乾燥
したところ、白色粉末状のポリマー(PCSと略す)9
9.4g(収率91.3%)が得られた。該PCSについて、1
H−NMR、IR、CHN分析、全ハロゲン定量(酸素
フラスコ燃焼法)およびGPC分析(標準物質ポリスチ
ン)を行つたところ、分子量Mn=15.0万、多分散度Mw
/Mn=1.6、CMS/STのモル比=1/9であつた。Then, by a conventional solution polymerization, a copolymerization reaction of 15.3 g (0.10 mol) of p-chloromethylstyrene (abbreviated as CMS) and 93.6 g (0.90 mol) of styrene (abbreviated as ST) was performed. A white polymer formed. After cooling the reaction mixed solution, the white polymer was taken out by decantation, and then reprecipitation was repeated three times with a tetrahydrofuran / methanol system to remove unreacted monomers and purify. The purified polymer was heated and dried under reduced pressure all day and night to give a white powdery polymer (abbreviated as PCS) 9
9.4 g (91.3% yield) was obtained. Regarding the PCS, 1
When H-NMR, IR, CHN analysis, total halogen determination (oxygen flask combustion method) and GPC analysis (standard substance polystin) were carried out, the molecular weight was Mn = 150,000 and the polydispersity was Mw.
/Mn=1.6, CMS / ST molar ratio = 1/9.
【0056】上述のようにして得られたQ 26.7g(0.06
6モル)とPCS 65.3g(CMS当量換算 0.060当量)
とをテトラヒドロフラン 850ml中、65℃で、64時間反応
させたところ、黄色ポリマーが生成した。反応混合物を
冷却後、エチルエーテル 2l中に加え、撹拌後、デカン
テーシヨンにより、ポリマーと取り出した。エチルエー
テル洗浄を3回繰り返したのち、ポリマーをメタノール
/テトラヒドロフラン系の混合溶媒に溶解し、水中に加
え再沈殿した。このようにして、精製したポリマーを一
昼夜加熱減圧乾燥したところ、黄色粉末状ポリマー(B
PCQと略す)74.1g(PCSに対する収率82.7%)が
得られた。Q 26.7 g (0.06) obtained as described above
6 mol) and PCS 65.3 g (CMS equivalent 0.060 equivalent)
When and were reacted in 850 ml of tetrahydrofuran at 65 ° C. for 64 hours, a yellow polymer was formed. After cooling the reaction mixture, it was added to 2 l of ethyl ether, and after stirring, the polymer was taken out by decantation. After washing with ethyl ether three times, the polymer was dissolved in a mixed solvent of methanol / tetrahydrofuran and added to water for reprecipitation. When the polymer thus purified was dried under reduced pressure with heating all day and night, a yellow powdery polymer (B
74.1 g (82.7% yield based on PCS) was obtained.
【0057】BPCQは前述のQ及びPCSと同様の分
析手法を用い、分析した結果、分子量Mn=17.0万、多
分散度Mw/Mn=1.8、四級化度=10.0%であつた。結
果を表1及び表2に示す。BPCQ was analyzed by using the same analysis method as for Q and PCS described above. As a result, the molecular weight was Mn = 17,000, the polydispersity was Mw / Mn = 1.8, and the degree of quaternization was 10.0%. The results are shown in Tables 1 and 2.
【0058】実施例2 攪拌機、還流コンデンサー、温度計及び滴下ロートをつ
けた 200ml 四ツ口フラスコにベンゼン 50ml 及びエタ
ノールアミン(和光純薬工業、試薬1級、以下EAと略
す)6.1g(0.1モル)を仕込んだ後、攪拌下、金属ナト
リウム 2.5g(0.11モル)を徐々に加えた。添加後、5
〜10℃で5時間反応させた。Example 2 In a 200 ml four-necked flask equipped with a stirrer, a reflux condenser, a thermometer and a dropping funnel, 50 ml of benzene and 6.1 g of ethanolamine (Wako Pure Chemical Industries, reagent grade 1, abbreviated as EA hereinafter). ) Was charged, 2.5 g (0.11 mol) of metallic sodium was gradually added with stirring. After addition, 5
The reaction was carried out at -10 ° C for 5 hours.
【0059】反応終了後、ベンゼンを除去し、実施例1
で得られたPCS 98.0g(CMSに対して0.090当量)
及びテトラハイドロフラン100mlを加え、還流下、24時
間反応させた。反応後、得られたポリマー(以下、PC
S−EAと略す)はアセトン/メタノールで再沈殿後、
洗浄、乾燥した。収量92.5g(EAに対する収率83.1
%)。After the completion of the reaction, benzene was removed and Example 1 was used.
98.0 g of PCS obtained in step (0.090 equivalent to CMS)
And 100 ml of tetrahydrofuran were added, and the mixture was reacted under reflux for 24 hours. After the reaction, the obtained polymer (hereinafter, PC
S-EA) is re-precipitated with acetone / methanol,
Washed and dried. Yield 92.5g (Yield to EA 83.1g
%).
【0060】次に、PCS−EA 92.5g(CMSに対し
て0.083当量)に40%ホルマリン溶液20g(HCHOに対
して0.27モル)及びギ酸 20g(0.43モル)を加え、60〜
80℃で8時間反応させた。得られたポリマー(以下PC
S−DAと略す)はアセトン/メタノール系で再沈殿、
洗浄、乾燥した。収量87.7g、PCS−EAに対する収
率89.0%。Next, to 92.5 g of PCS-EA (0.083 equivalent to CMS), 20 g of 40% formalin solution (0.27 mol to HCHO) and 20 g of formic acid (0.43 mol) were added, and the mixture was added to 60-
The reaction was carried out at 80 ° C for 8 hours. Obtained polymer (hereinafter PC
(Abbreviated as S-DA) is reprecipitated with an acetone / methanol system,
Washed and dried. Yield 87.7 g, 89.0% yield based on PCS-EA.
【0061】該PCS−DA 87.7g(CMSに対して0.
074当量)、LB 21.2g(0.085モル)及びエチルアルコ
ール 100mlを500mlナス型フラスコに入れて90℃、24時
間反応させ、ポリマー(以下PCS−TAと略す)93.1
gを得た。対PCS−DA収率90.5%。87.7 g of the PCS-DA (0.
074 equivalent), LB 21.2 g (0.085 mol) and 100 ml of ethyl alcohol were placed in a 500 ml eggplant-shaped flask and reacted at 90 ° C. for 24 hours to give a polymer (hereinafter abbreviated as PCS-TA) 93.1.
got g. Yield to PCS-DA 90.5%.
【0062】PCS−TAは実施例1のBPCQと同様
の分析により、分子量Mn=19.0万、多分散度Mw/Mn
=1.9、四級化度=10.0%であつた。結果を表1及び表
2に示す。PCS-TA was analyzed in the same manner as in BPCQ of Example 1, and had a molecular weight Mn of 190,000 and a polydispersity Mw / Mn.
= 1.9, quaternization degree = 10.0%. The results are shown in Tables 1 and 2.
【0063】実施例3 実施例1で得られたPCS 40.3g(CMSに対して0.03
7当量)にテトラクロロエチレンを加え、撹拌下に、N
−メチル−N−ドデシルアミン 11.1g(0.056モル)を
滴下、4時間還流後、苛性カリ水溶液とメタノール混合
液中に、反応混合物を入れ、遊離アミンが検出されなく
なるまでメタノールで洗浄した。生成したポリマー(以
下PCS−AAと略す)の収量42.5g、収率91.9%(対
PCS)であつた。Example 3 40.3 g of PCS obtained in Example 1 (0.03 with respect to CMS)
Tetrachloroethylene was added to
11.1 g (0.056 mol) of -methyl-N-dodecylamine was added dropwise, and after refluxing for 4 hours, the reaction mixture was put into a mixed solution of potassium hydroxide aqueous solution and methanol, and washed with methanol until no free amine was detected. The yield of the produced polymer (hereinafter abbreviated as PCS-AA) was 42.5 g, and the yield was 91.9% (vs. PCS).
【0064】次に該ポリマー PCS−AA 42.5g(C
MSに対して0.036当量)とモノクロロ酢酸メチル 5.5g
(0.051モル)をテトラクロロエチレン溶液中、撹拌
下、4時間還流した。次に、この混合溶液に1−NのN
aOH水溶液を加え、アルカリ性にした後、濾過、メタ
ノールで洗浄した。加熱減圧乾燥後、白色粉末状のポリ
マー(PCT−BTと略す)が41.9g(対PCS−AA
収率94.1%)得られた。尚、PCS−BTはオレンジ−
II法による比色定量によつて定量した。Next, 42.5 g of the polymer PCS-AA (C
0.036 equivalents to MS) and methyl monochloroacetate 5.5g
(0.051 mol) was refluxed in a tetrachloroethylene solution for 4 hours with stirring. Next, 1-N N was added to this mixed solution.
After adding an aqueous solution of aOH to make the solution alkaline, it was filtered and washed with methanol. After heating under reduced pressure, 41.9 g of white powdery polymer (abbreviated as PCT-BT) (vs. PCS-AA)
Yield 94.1%) was obtained. PCS-BT is orange-
It was quantified by colorimetric determination by method II.
【0065】また、実施例1と同様の分析により分子量
Mn=21.4万、多分散度Mw/Mn=2.9、四級化度=10.0
%であつた。結果を表1及び表2に示す。Further, by the same analysis as in Example 1, molecular weight Mn = 214,000, polydispersity Mw / Mn = 2.9, quaternization degree = 10.0.
It was in%. The results are shown in Tables 1 and 2.
【0066】実施例4 N,N,N',N'−テトラメチル−1,6−ジアミノヘキサン
(以下TMHと略す)27.5g(0.16モル)をアセトニト
リル 50mlに溶解し室温で撹拌下これにLB 10.0g(0.0
4モル)を滴下、引き続いて70℃で3時間加熱した。次
に反応液を室温まで冷却し、生じた白色沈殿を濾過する
と、N,N,N',N'−テトラメチル−1,6−ジアミノヘキ
サン−N,N'−ジラウリルジブロマイドが0.13g(対L
B副生率 1.0%)副生していた。濾液を減圧下で濃縮し
大部分のTMHを留去し、生じた白色ペースト状残渣を
ヘキサン 40mlで洗浄し、デカンテーシヨンによりヘキ
サン層を分離すると未反応TMHが完全に除去され、白
色ワツクス状物質が得られた。このものを真空ポンプで
減圧乾燥するとN,N,N',N'−テトラメチル−1,6−ジ
アミノヘキサン−N−ラウリルブロマイド(以下TML
−C6と略す)が15.6g生成していた(耐LB収率92.5
%)。Example 4 27.5 g (0.16 mol) of N, N, N ', N'-tetramethyl-1,6-diaminohexane (hereinafter abbreviated as TMH) was dissolved in 50 ml of acetonitrile, and LB was added thereto while stirring at room temperature. 10.0 g (0.0
4 mol) was added dropwise, followed by heating at 70 ° C. for 3 hours. Next, the reaction solution was cooled to room temperature, and the white precipitate formed was filtered to give 0.13 g of N, N, N ', N'-tetramethyl-1,6-diaminohexane-N, N'-dilauryl dibromide. (Vs L
B byproduct rate 1.0%) It was a byproduct. The filtrate was concentrated under reduced pressure to remove most of TMH, the resulting white paste-like residue was washed with 40 ml of hexane, and the hexane layer was separated by decantation to completely remove unreacted TMH and form a white wax. Material was obtained. When this was dried under reduced pressure with a vacuum pump, N, N, N ', N'-tetramethyl-1,6-diaminohexane-N-lauryl bromide (hereinafter TML
15.6 g was produced (abbreviated as C 6 ).
%).
【0067】TML−C6 15.6g(37ミリモル)をアセ
トン 200mlに溶解し室温で撹拌下これに4−クロルメチ
ルスチレン 5.2g(34ミリモル)を滴下した。次に50℃
で17時間加熱すると白色結晶が析出してきた。反応液を
室温まで冷却し生じた白色結晶を濾過して単離し冷アセ
トンで洗浄後乾燥するとN,N,N',N'−テトラメチル
−N−ラウリル−N'−(4−ビニル)ベンジルヘキサ
メチレンジアンモニウムブロマイドクロライド(TML
S−C6と略す)が17.2g(対CMS収率88.2%)が生成
していた。TML-C 6 (15.6 g, 37 mmol) was dissolved in 200 ml of acetone, and 5.2 g (34 mmol) of 4-chloromethylstyrene was added dropwise thereto with stirring at room temperature. Then 50 ℃
After heating for 17 hours, white crystals started to precipitate. The reaction solution was cooled to room temperature, the resulting white crystals were isolated by filtration, washed with cold acetone and dried to give N, N, N ', N'-tetramethyl-N-lauryl-N'-(4-vinyl) benzyl. Hexamethylenediammonium bromide chloride (TML
17.2 g (abbreviated as S-C 6 ) was produced (relative to CMS yield 88.2%).
【0068】上記TMLS−C6 5.7g(10ミリモル)と
スチレン 9.4g(90ミリモル)をメタノール 10mlに溶解
しこれにAIBN 50mg(0.3ミリモル)をメタノール
2mlに溶解した液を加えた。この混合物を窒素雰囲気下
で65℃で22時間撹拌すると粘稠溶液となつた。反応液を
多量の水中に投入して重合反応を停止し生じた白色重合
体を濾過して単離し、減圧乾燥することにより白色ポリ
マーを得た。メタノールに再溶解後、酢酸エチル中に投
入する操作を2回繰り返して精製、乾燥することにより
白色粉末状ポリマー(OBAQと略す)を14.3g(収率9
4.8%)を得た。5.7 g (10 mmol) of TMLS-C 6 and 9.4 g (90 mmol) of styrene were dissolved in 10 ml of methanol, and 50 mg of AIBN (0.3 mmol) was dissolved in methanol.
A solution dissolved in 2 ml was added. The mixture became a viscous solution when stirred at 65 ° C. for 22 hours under nitrogen atmosphere. The reaction solution was poured into a large amount of water to stop the polymerization reaction, and a white polymer produced was filtered and isolated, and dried under reduced pressure to obtain a white polymer. After re-dissolving in methanol, the operation of charging in ethyl acetate was repeated twice, and purified and dried to obtain 14.3 g of white powdery polymer (abbreviated as OBAQ) (yield 9
4.8%) was obtained.
【0069】OBAQはTLC、IR、1H−NMR及
びCHN分析より、TMLS−C6とスチレンとの共重
合体であることを確認した。尚、GPC分析の結果から
ポリスチレンを標準物質として、分子量Mn=16.0万、
多分散度Mw/Mn=3.1であつた。コロイド滴定法と全
ハロゲン定量(酸素フラスコ燃焼法)から、第四級アン
モニウム塩の含有量を定量したところ、11.5%であつ
た。結果を表1及び表2に示す。OBAQ was confirmed to be a copolymer of TMLS-C 6 and styrene by TLC, IR, 1 H-NMR and CHN analysis. From the results of GPC analysis, polystyrene was used as a standard substance and the molecular weight was Mn = 16,000,
The polydispersity was Mw / Mn = 3.1. The content of the quaternary ammonium salt was determined by colloid titration and total halogen determination (oxygen flask combustion method), and it was 11.5%. The results are shown in Tables 1 and 2.
【0070】実施例5 実施例4で得られた化合物OBAQ 15.1g(10ミリ当
量)をメタノール/水=1/4の混合溶媒2l中に溶解
後、無水酢酸ソーダ 49.2g(0.60モル)を加え、室温で
24時間、撹拌を続けた。この溶液を濃縮した後、真空ポ
ンプで室温下に、減圧乾燥したところ、白色粉末状混合
物が得られた。該白色粉末状混合物にクロロホルム 300
mlを加え、ナトリウム塩を濾別した後、クロロホルム溶
液を濃縮し、析出した白色粉末を、一昼夜、加熱減圧乾
燥したところ、白色粉末ポリマー(OBAAと略す)が
13.0g(8.9ミリ当量)生成していた(OBAQに対する
OBAAの収率89%)。実施例4と同様の分析を実施し
た結果を表1及び表2に示す。Example 5 15.1 g (10 meq) of the compound OBAQ obtained in Example 4 was dissolved in 2 l of a mixed solvent of methanol / water = 1/4, and 49.2 g (0.60 mol) of anhydrous sodium acetate was added. At room temperature
Stirring was continued for 24 hours. The solution was concentrated and then dried under reduced pressure at room temperature with a vacuum pump to obtain a white powdery mixture. Chloroform 300 was added to the white powder mixture.
After adding ml and filtering off the sodium salt, the chloroform solution was concentrated, and the precipitated white powder was dried under heating and reduced pressure for one day and night. As a result, a white powder polymer (abbreviated as OBAA) was obtained.
13.0 g (8.9 meq) was produced (89% yield of OBAA based on OBAQ). The results of performing the same analysis as in Example 4 are shown in Tables 1 and 2.
【0071】比較例1〜2 市販抗菌剤 塩化ベンザルコニウム(BACと略す)を
比較例1、市販抗菌剤銀含有ゼオライト系化合物(Ag
−Zと略す)を比較例2とした。Comparative Examples 1-2 Commercially available antibacterial agent Benzalkonium chloride (abbreviated as BAC) was used as Comparative Example 1, commercial antibacterial agent silver-containing zeolite compound (Ag
Comparative Example 2 is abbreviated as -Z).
【0072】実施例6 眼鏡フレームへのコーテイング 500mlのビーカー5個にシンナー(CS−50)165gづ
つ入れ、次に、実施例1,2,3,4及び5でそれぞれ
得られた化合物BPCQ、PCS−TA、PCS−B
T、OBAQ及びOBAAを1gづつ加えた後、約10分
間、超音波処理することによつて溶解させ、均一溶液と
した。このシンナー溶液にAC970クリアー樹脂(アク
リル樹脂/アミノ樹脂ワニス=50/50w/w)を99gづつ加
え、室温で約1時間、撹拌し溶解させた。次いで、この
樹脂混合液を常法に従つて、メタル眼鏡フレームにスプ
レー加工し、45℃で60分間乾燥させた。Example 6 Coating on spectacle frame Five beakers of 500 ml each were charged with 165 g of thinner (CS-50), and then the compounds BPCQ and PCS obtained in Examples 1, 2, 3, 4 and 5, respectively. -TA, PCS-B
After adding 1 g each of T, OBAQ and OBAA, they were dissolved by ultrasonic treatment for about 10 minutes to obtain a uniform solution. To this thinner solution, 99 g of AC970 clear resin (acrylic resin / amino resin varnish = 50/50 w / w) was added and dissolved by stirring at room temperature for about 1 hour. Then, this resin mixture was sprayed on a metal spectacle frame according to a conventional method, and dried at 45 ° C. for 60 minutes.
【0073】尚、比較のために実施例6で用いた化合物
に代えて、比較例1及び2の化合物BAC及びAg−Z
をそれぞれ1gづつ用いた他は実施例6と同様の操作な
らびに後処理をして、抗菌性眼鏡フレームを得た。Instead of the compound used in Example 6 for comparison, the compounds BAC and Ag-Z of Comparative Examples 1 and 2 were used.
The same operations and post-treatments as in Example 6 were carried out except that 1 g each was used to obtain antibacterial eyeglass frames.
【0074】比較例3 ブランク(未抗菌処理眼鏡フレ
ーム) 実施例6において化合物BPCQ等を使用しない他は実
施例6と同様の操作ならびに処理をして、未抗菌処理眼
鏡フレームを得、これをブランクとした。Comparative Example 3 Blank (Unantibacterial Treated Eyeglass Frame) The same operation and treatment as in Example 6 were carried out except that the compound BPCQ and the like were not used in Example 6 to obtain an unantibacterial treated eyeglass frame, which was blanked. And
【0075】試験例1 眼鏡フレーム湯洗虐待試験 抗菌力の持続性を比較する目的で実施例6及び比較例3
で得られた眼鏡フレームを虐待前とし、各々を1コづ
つ、1lの沸騰水中に、別々に浸し、15分間、煮沸を続
け、湯洗虐待とした。本虐待後、該フレームを約24時
間、60℃で乾燥したものを湯洗虐待後の眼鏡フレームと
した。Test Example 1 Eyeglass Frame Bath Wash Abuse Test Example 6 and Comparative Example 3 for the purpose of comparing the persistence of antibacterial activity.
Before the abuse, the eyeglass frames obtained in 1. were individually immersed in 1 liter of boiling water, and boiled for 15 minutes to be treated with hot water. After the main abuse, the frame was dried at 60 ° C. for about 24 hours, and used as eyeglass frames after bath-wash abuse.
【0076】試験例2 眼鏡フレームの抗菌試験 供試眼鏡フレームとして、実施例6及び比較例3で得ら
れた虐待前の眼鏡フレームならびにそれらを試験例1で
虐待した後の眼鏡フレームをそれぞれ用いた。供試菌と
しては、皮膚常在細菌である黄色ブドウ球菌 Staphylo
coccus aureusIFO 12732を用いて試験した。ま
ず、Nutrient broth (Difco.Lab.)で18時間振盪
培養した菌を無菌水で104cells/mlに希釈し菌液とし
た。次に、供試眼鏡フレームをポリプロピレン製ガスバ
リヤー性袋(180×80cm)に入れ、前述の菌液を50ml入
れ、熱シールした。37℃の恒温振盪培養装置に、この眼
鏡フレーム入り袋をセツトし、18時間培養試験した。培
養試験後、菌液を採取し、常法にしたがつて、コロニー
カウント法により、残存生菌数を計測した。試験結果を
表3〜4に示す。Test Example 2 Antibacterial Test of Eyeglass Frame As the test eyeglass frame, the eyeglass frames before the abuse obtained in Example 6 and Comparative Example 3 and the eyeglass frames after the abuse in Test Example 1 were used, respectively. . Staphylo Staphylococcus aureus, which is a skin-resident bacterium, is used as the test bacterium.
Tested with coccus aureus IFO 12732. First, a bacterium that was shake-cultured for 18 hours in a nutrient broth (Difco. Lab.) Was diluted to 10 4 cells / ml with sterile water to obtain a bacterium solution. Next, the sample eyeglass frame was placed in a polypropylene gas barrier bag (180 × 80 cm), 50 ml of the above-mentioned bacterial solution was placed therein, and heat sealed. The bag containing the spectacle frame was set in a constant temperature shaking culture device at 37 ° C., and a culture test was performed for 18 hours. After the culture test, the bacterial solution was collected, and the number of remaining viable bacteria was measured by the colony counting method according to a conventional method. The test results are shown in Tables 3-4.
【0077】[0077]
【表1】 [Table 1]
【0078】[0078]
【表2】 [Table 2]
【0079】[0079]
【表3】 [Table 3]
【0080】[0080]
【表4】 [Table 4]
【0081】初発菌数(a): 62,000 cells/ml 殺菌指数=log〔(b/a)×100〕 なお今回は生菌数が0となり、上式が不成立となるので
生菌数を1として殺菌指数を計算した。Initial number of bacteria (a): 62,000 cells / ml Bactericidal index = log [(b / a) × 100] Since the number of viable bacteria was 0 this time and the above equation was not satisfied, the number of viable bacteria was set to 1. The bactericidal index was calculated.
【0082】表4より、湯洗虐待後においても、市販抗
菌剤を使用したものより、本発明の化合物を使用したも
のの方が抗菌効果が優れていることが明らかである。From Table 4, it is clear that even after the bath-washing abuse, the antibacterial effect of the compound of the present invention is superior to that of the commercially available antibacterial agent.
【0083】試験例3 以下の方法により皮膚一次刺激性試験を行つた。 供試動物 ニユージーランドホワイト種の若齢雌ウサギ(アイラン
ドスキンフリー)を株式会社井上実験動物センターより
入手した。入手時の月齢は4ケ月齢で、体重は2.83〜3.
08kgであつた。飼育室は温度22±1℃、湿度55〜66%、
換気回数15回/時間、照明時間12時間/日(午前7時〜
午後7時)であつた。動物は簡易水洗飼育機(日本ケー
ジ株式会社)に装着されたアルミニウム製ケージ(32×
55×35cm)に個別飼育した。動物には実験動物用固型飼
料RC4(オリエンタル酵母工業株式会社)を自由摂取
させた。水は自動給水システムにより水道水を各ケージ
に供給し自由摂取させた。動物は試験開始前1週間以
上、上述の飼育環境に馴化した。Test Example 3 A primary skin irritation test was conducted by the following method. Test animals Young white rabbits of New Zealand White (island skin free) were obtained from Inoue Laboratory Animal Center. The age at the time of acquisition is 4 months, and the weight is 2.83-3.
It was 08 kg. The temperature of the breeding room is 22 ± 1 ℃, the humidity is 55-66%,
Ventilation rate 15 times / hour, lighting time 12 hours / day (7:00 am ~
It was 7pm). The animal is an aluminum cage (32 x
55 x 35 cm) were individually bred. The animals were allowed to freely ingest solid feed RC4 for experimental animals (Oriental Yeast Co., Ltd.). As for water, tap water was supplied to each cage by an automatic water supply system to allow free intake. The animals were acclimated to the above-mentioned breeding environment for 1 week or more before the start of the test.
【0084】被験物質の調製 実施例1〜5の化合物を予め乳鉢内で0.5gの被験物質に
0.5mlの注射用蒸留水を加えペースト状にし、その全量を
回収しリント布に塗布した。 暴露方法 予備飼育中に動物の背部被毛を電気バリカン(THRIVE A
NIMAL CLIPPER MODEL900,株式会社夏目製作所)で軽く
刈毛し、アイランドスキンの少ない3匹の動物を選抜し
た。試験開始約24時間前に動物の背部被毛を同様に刈毛
し、除毛剤(エバクレーム,東京田辺製薬株式会社)で
除毛した。試験部位として各動物当たり脊椎中線の左右
それぞれ2カ所ずつ計4カ所を設けた。被験物質は上述
のとおり(被験物質の調整に記載)2.5×2.5cm2のリン
ト布(西尾衛生材料株式会社)に均一に塗布し、それら
を絆創膏(ダーミセル,株式会社東京衛材研究所)を用
いて試験部位の皮膚に閉塞添付した。対照として0.5ml
の注射用蒸留水を塗布したリント布のみを同様に貼付し
た。リント布の貼付は試験部位毎の感受性の差を考慮
し、動物毎に無作為に選んだ。暴露時間は4時間とし、
暴露終了時に、皮膚に残存した被験物質は微温湯を浸し
た脱脂綿で軽く拭き取ることにより除去した。Preparation of test substance The compounds of Examples 1 to 5 were preliminarily placed in a mortar to give 0.5 g of the test substance.
0.5 ml of distilled water for injection was added to form a paste, and the whole amount was collected and applied to a lint cloth. Exposure method The hair on the back of the animal during preliminary breeding was cut with an electric hair clipper (THRIVE A
NIMAL CLIPPER MODEL900, Natsume Seisakusho Co., Ltd.), lightly shaved the hair, and selected 3 animals with little island skin. Approximately 24 hours before the start of the test, the back hair of the animal was similarly shaved and hair was removed with a hair remover (Eva Claim, Tokyo Tanabe Seiyaku Co., Ltd.). As test sites, a total of 4 sites were provided for each animal, two on each side of the midline of the spine. The test substance was applied uniformly to 2.5 × 2.5 cm 2 lint cloth (Nishio Sanitary Material Co., Ltd.) as described above (described in Preparation of test substance), and they were applied with a plaster (Dermicelle, Tokyo Hygiene Institute Co., Ltd.). It was used to occlude the skin at the test site. 0.5 ml as a control
Only the lint cloth coated with distilled water for injection was attached in the same manner. The application of lint cloth was randomly selected for each animal in consideration of the difference in sensitivity between test sites. Exposure time is 4 hours,
At the end of the exposure, the test substance remaining on the skin was removed by gently wiping it with absorbent cotton soaked in lukewarm water.
【0085】観察項目 暴露終了後の試験部位における皮膚反応は、OECDの
皮膚刺激性の評価基準[表5]に従つて評価した。観察
時間は暴露終了後30分及び暴露後1日から皮膚反応の消
失するまでとし、最長14日後まで観察した。結果を表6
に示した。Observation Items The skin reaction at the test site after the exposure was evaluated according to the evaluation criteria for skin irritation of OECD [Table 5]. The observation time was 30 minutes after the end of the exposure and 1 day after the exposure until the skin reaction disappeared, and the observation was performed up to 14 days later. The results are shown in Table 6.
It was shown to.
【0086】[0086]
【表5】紅斑及び痂皮の形成 紅斑なし……………………………………………………………………………0 非常に軽度の紅斑(かろうじて識別できる)…………………………………1 はつきりした紅斑…………………………………………………………………2 中等度ないし高度紅斑……………………………………………………………3 高度紅斑(beet redness)からわずかな痂皮の形成(深部損傷)まで……4 最高点4浮腫の形成 浮腫なし……………………………………………………………………………0 非常に軽度の浮腫(かろうじて識別できる)…………………………………1 軽度浮腫(はつきりした膨隆による明確な縁が識別できる)………………2 中等度浮腫(約1mmの膨隆)……………………………………………………3 高度浮腫(1mmの膨隆と暴露範囲を越えた広がり)…………………………4 最高点4[Table 5] Erythema and crust formation No erythema ………………………………………………………………………… 0 Very mild erythema (barely distinguishable) Yes) ………………………………………… 1 is the erythema that was associated with …………………………………………………………………… 2 Moderate or not High-grade erythema ………………………………………………………… 3 From high-grade erythema (beet redness) to slight crust formation (deep damage) …… 4 Highest score 4 Edema formation No edema ………………………………………………………………………… 0 Very mild edema (barely distinguishable) …………… …………………… 1 Mild edema (a clear edge can be identified due to bulging bulge) ……………… 2 Moderate edema (bulge of about 1 mm) ………………………… ………………………………… 3 Advanced edema Beyond the bulging and exposure range of 1mm spread) .............................. 4 highest point 4
【0087】[0087]
【表6】 [Table 6]
【0088】表6中、Aは紅斑及び痂皮を、Bは浮腫を
示す。表6の結果より、本発明化合物は皮膚刺激性がな
いことがわかる。従つて、眼鏡フレームに該化合物をコ
ーテイングしても、安心して使用することができる。In Table 6, A indicates erythema and crust, and B indicates edema. From the results in Table 6, it can be seen that the compounds of the present invention have no skin irritation. Therefore, even if the spectacle frame is coated with the compound, it can be used with confidence.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 池田 正雄 福井県福井市花堂南2丁目7番5号 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Masao Ikeda 2-7-5 Hanado Minami, Fukui City, Fukui Prefecture
Claims (3)
ム及び眼鏡部品の表面をコーテイングすることを特徴と
する眼鏡フレーム及び眼鏡部品に抗菌性を付与するため
の処理方法。1. A treatment method for imparting antibacterial properties to an eyeglass frame and an eyeglass component, which comprises coating the surfaces of the eyeglass frame and the eyeglass component with an antibacterial polymer.
ルモノマーから誘導される構成単位と一般式化1で表わ
される構成単位を含むビニル系共重合体を有効成分とす
るポリマーからなる請求項1の処理方法。 【化1】 〔式中R1は水素原子又はメチル基を、Aはフエニレン
基を、R2は炭素数1〜2のアルキレン基を、Bは第4
級アンモニウム塩またはベタイン型化合物を含有する基
を示し、Aは置換基を含んでいてもよい。〕2. The antibacterial polymer is a polymer containing a vinyl copolymer containing a structural unit derived from a non-crosslinkable vinyl monomer and a structural unit represented by the general formula 1 as an active ingredient. Processing method. [Chemical 1] [In the formula, R 1 represents a hydrogen atom or a methyl group, A represents a phenylene group, R 2 represents an alkylene group having 1 to 2 carbon atoms, and B represents a fourth group.
A group containing a primary ammonium salt or a betaine compound is shown, and A may contain a substituent. ]
化5で表わされる基である請求項2の処理方法。 【化2】 【化3】 【化4】 【化5】 〔式中、ビピリジンは、4,4'−,2,2'−,2,3'−,2,4'
−,3,3'−,3,4'−の異性体を示し、X, Yはアニオン
で同一又は異なつていてもよく、X, Yがそれぞれ1価
のアニオン或いは(X, Y)が2価のアニオン1個であ
つてもよい。R3は炭素数6〜18のアルキル基、R4は炭
素数2〜10のアルキレン基、R5〜R8は同一又は異なつ
ていてもよく、炭素数1〜3のアルキル基、R9は炭素
数1〜3のアルキレン基を示し、いずれも置換基を含ん
でいてもよい。〕3. In the compound (1), B is represented by the general formula 2 to
The treatment method according to claim 2, which is a group represented by Chemical formula 5. [Chemical 2] [Chemical 3] [Chemical 4] [Chemical 5] [In the formula, bipyridine is 4,4'-, 2,2'-, 2,3'-, 2,4 '
-, 3,3'-, 3,4'- isomers are shown, and X and Y may be the same or different anions, and X and Y are monovalent anions or (X, Y) respectively. It may be one divalent anion. R 3 is an alkyl group having 6 to 18 carbon atoms, R 4 is an alkylene group having 2 to 10 carbon atoms, R 5 to R 8 may be the same or different, and are an alkyl group having 1 to 3 carbon atoms, R 9 Represents an alkylene group having 1 to 3 carbon atoms, and each may contain a substituent. ]
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16413793A JPH06347733A (en) | 1993-06-07 | 1993-06-07 | Treatment to give antimicrobial property to frame of spectacles and parts of spectacles |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16413793A JPH06347733A (en) | 1993-06-07 | 1993-06-07 | Treatment to give antimicrobial property to frame of spectacles and parts of spectacles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH06347733A true JPH06347733A (en) | 1994-12-22 |
Family
ID=15787456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16413793A Pending JPH06347733A (en) | 1993-06-07 | 1993-06-07 | Treatment to give antimicrobial property to frame of spectacles and parts of spectacles |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH06347733A (en) |
-
1993
- 1993-06-07 JP JP16413793A patent/JPH06347733A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100590127C (en) | Heterocyclic halamine siloxanes for use in biocidal coatings and materials | |
| US20090324536A1 (en) | Antimicrobial polymers and coatings | |
| JPH06239997A (en) | Novel polymeric antimicrobial agents and their use in pharmaceutical compositions | |
| US4532128A (en) | Quaternary ammonium group-containing polymers having antimicrobial activity | |
| DE69307112T2 (en) | POLYMERIZABLE MONOMER, POLYMERS AND METHOD FOR THE PRODUCTION THEREOF | |
| CA2003173A1 (en) | Antimicrobial compositions | |
| EP0641805A1 (en) | Antimicrobial polymers and compositions containing them | |
| JPWO1992014365A1 (en) | antibacterial agents | |
| JPH06347733A (en) | Treatment to give antimicrobial property to frame of spectacles and parts of spectacles | |
| JPH0774125B2 (en) | Antibacterial composition | |
| US5786386A (en) | Antibacterial and fungicidal agent | |
| JP3274546B2 (en) | Antibacterial paper | |
| JPH06279214A (en) | Sterilization and disinfection of hand finger | |
| US2861902A (en) | Addition products of heterocyclic nitrogen polymers and heavy metal salts, method ofimpregnating with, and impregnated article | |
| JP3171691B2 (en) | Copolymer and method for producing the same | |
| JP3476854B2 (en) | Polycationic fungicide | |
| AU2001293022A1 (en) | Processes to control the residual monomer level of copolymers of tertiary amino monomer with a vinyl-functional monomer | |
| JP3353869B2 (en) | Antimicrobial composition | |
| EP1322684A2 (en) | Processes to control the residual monomer level of copolymers of tertiary amino monomer with a vinyl-functional monomer | |
| JPH0232101A (en) | Novel chitosan compound, production of said compound and humectant containing said compound | |
| JP3205063B2 (en) | Polymerizable monomer and method for producing the same | |
| JPH0680732A (en) | Vinyl copolymer | |
| JPH0687701A (en) | Disinfectant for sterilizing antibiotic-resistant bacterium | |
| JP3154075B2 (en) | Antibacterial agent | |
| JP2004068174A (en) | Stimulation inhibitor for fiber, composition, treatment method, and hypoallergenic fiber |